Home NDC 42337-201 Sertraline Hydrochloride
Product NDC 42337-201
11-digit product format 423370201
Labeler code 42337
Product ID 42337-201_e8c17511-93ca-2cf2-e053-2a95a90a1dde
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name sertraline hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Viwit Pharmaceutical Co., Ltd.
Application ANDA076882
Marketing category ANDA
Marketing start 2021-02-28
Marketing end 0000-00-00
Substance SERTRALINE HYDROCHLORIDE
Active strength 25 mg/1
Pharmacologic classes Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076882-001 SERTRALINE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE EQ 25MG BASE TABLET / ORAL AB 2007-02-06 A076882-002 SERTRALINE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE EQ 50MG BASE TABLET / ORAL AB 2007-02-06 A076882-003 SERTRALINE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE EQ 100MG BASE TABLET / ORAL AB 2007-02-06
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A076882-001 SERTRALINE HYDROCHLORIDE EQ 25MG BASE TABLET / ORAL AB 2007-02-06 a50c72e98297…2026-08-01 22:54:32 2026-06 A076882-002 SERTRALINE HYDROCHLORIDE EQ 50MG BASE TABLET / ORAL AB 2007-02-06 a50c72e98297…2026-08-01 22:54:32 2026-06 A076882-003 SERTRALINE HYDROCHLORIDE EQ 100MG BASE TABLET / ORAL AB 2007-02-06 a50c72e98297…
Observed Orange Book normalized TE history# DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 42337-201-01 Sertraline Hydrochloride 30 in 1 BOTTLE TABLET, FILM COATED 30 1 42337-201-02 Sertraline Hydrochloride 60 in 1 BOTTLE TABLET, FILM COATED 60 1 42337-201-03 Sertraline Hydrochloride 90 in 1 BOTTLE TABLET, FILM COATED 90 1 42337-201-04 Sertraline Hydrochloride 180 in 1 BOTTLE TABLET, FILM COATED 180 1 42337-201-05 Sertraline Hydrochloride 500 in 1 BOTTLE TABLET, FILM COATED 500 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42337-201 SERTRALINE HYDROCHLORIDE TABLET, FILM COATED [VIWIT PHARMACEUTICAL CO., LTD.] 1 Legacy NDC, 5 package rows 20220922_e8c184d1-d4a0-7777-e053-2995a90a51cc.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 42337-201-01 42337020101 30 TABLET, FILM COATED in 1 BOTTLE (42337-201-01) 2021-02-28 0000-00-00 No No Current 42337-201-02 42337020102 60 TABLET, FILM COATED in 1 BOTTLE (42337-201-02) 2021-02-28 0000-00-00 No No Current 42337-201-03 42337020103 90 TABLET, FILM COATED in 1 BOTTLE (42337-201-03) 2021-02-28 0000-00-00 No No Current 42337-201-04 42337020104 180 TABLET, FILM COATED in 1 BOTTLE (42337-201-04) 2021-02-28 0000-00-00 No No Current 42337-201-05 42337020105 500 TABLET, FILM COATED in 1 BOTTLE (42337-201-05) 2021-02-28 0000-00-00 No No Current